Boston Scientific Corporation logo

Boston Scientific Corporation (BSX)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
97. 52
-0.2
-0.2%
$
149.67B Market Cap
74.55 P/E Ratio
0% Div Yield
6,584,632 Volume
2.01 Eps
$ 97.72
Previous Close
Day Range
97.02 98.69
Year Range
85.98 109.5
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 60 days
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)

3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Will FARAPULSE Line Aid Boston Scientific's Q3 Earnings?

Will FARAPULSE Line Aid Boston Scientific's Q3 Earnings?

BSX is expected to have registered strong growth in the Asia Pacific, which is led by strength in China and Japan.

Zacks | 1 year ago
Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?

Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) reachead $86.20 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.

Zacks | 1 year ago
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

Here is how Boston Scientific (BSX) and Arcellx, Inc. (ACLX) have performed compared to their sector so far this year.

Zacks | 1 year ago
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?

Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 1 year ago
3 Profitable S&P 500 Stocks for the Best Quarter of the Year

3 Profitable S&P 500 Stocks for the Best Quarter of the Year

Royal Caribbean Cruises, Boston Scientific and Monolithic Power Systems have been selected as the top picks with a high net income ratio.

Zacks | 1 year ago
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the most recent trading session, Boston Scientific (BSX) closed at $84.54, indicating a +0.86% shift from the previous trading day.

Zacks | 1 year ago
Why Boston Scientific (BSX) Outpaced the Stock Market Today

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed at $84.49 in the latest trading session, marking a +0.42% move from the prior day.

Zacks | 1 year ago
Here's Why You Should Add BSX Stock to Your Portfolio Now

Here's Why You Should Add BSX Stock to Your Portfolio Now

Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive MedSurg market share gain.

Zacks | 1 year ago
3 MedTech Stocks to Buy as Monetary Policy Eases

3 MedTech Stocks to Buy as Monetary Policy Eases

Here, we pick three MedTech stocks, VCYT, BSX and PAHC, which are anticipated to gain strongly in 2024 from the loosening of monetary policy.

Zacks | 1 year ago
Loading...
Load More